Science news articles about 'insulin analogues'

It has so far not been proven that long-acting insulin analogues (LAIAs) have an advantage over conventional human insulin in the treatment of patients with type 2 diabetes. Even though the results of ...

... type 2 diabetes. Researchers in Germany conclude that even though one of two long-acting insulin analogues investigated has been on the market for 9 years, its benefits and harms have still not been ...

... 2). The data were evaluated of approximately 130,000 patients with diabetes who had used either human insulin or an insulin analogue exclusively, and who had not developed malignancies up to 2001.